Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-11 4:43 pm Sale |
2020-12-31 | 13G | Curis, Inc. CRIS |
BIOTECHNOLOGY VALUE FUND L P | 31,347 1.000% |
-151,153 (-82.82%) |
Filing History |
| 2021-02-11 4:41 pm Sale |
2020-12-31 | 13G | AnaptysBio, Inc. ANAB |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-1,441,565 (Position Closed) |
Filing History |
| 2021-02-11 4:33 pm Sale |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,740,000 (Position Closed) |
Filing History |
| 2021-02-11 4:30 pm Sale |
2020-12-31 | 13G | Brickell Biotech, Inc. BBI |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-14,757 (Position Closed) |
Filing History |
| 2021-02-11 4:22 pm Purchase |
2020-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 931,750 6.600% |
404,333 (+76.66%) |
Filing History |
| 2021-02-01 5:19 pm Purchase |
2021-01-22 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
BIOTECHNOLOGY VALUE FUND L P | 3,138,678 7.200% |
1,875,000 (+148.38%) |
Filing History |
| 2021-01-29 4:36 pm Sale |
2021-01-27 | 13D | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 408,194 20.400% |
-38,000 (-8.52%) |
Filing History |
| 2021-01-26 5:26 pm Sale |
2021-01-22 | 13D | Infinity Pharmaceuticals, Inc. INFIQ |
BIOTECHNOLOGY VALUE FUND L P | 10,726,968 16.700% |
-6,700,000 (-38.45%) |
Filing History |
| 2021-01-19 5:21 pm Purchase |
2021-01-06 | 13G | Aileron Therapeutics, Inc. ALRN |
BIOTECHNOLOGY VALUE FUND L P | 263,278 6.300% |
263,278 (New Position) |
Filing History |
| 2021-01-14 4:48 pm Sale |
2021-01-12 | 13G | AC Immune SA ACIU |
BIOTECHNOLOGY VALUE FUND L P | 7,916,658 11.000% |
-3,425,847 (-30.20%) |
Filing History |
| 2021-01-13 4:56 pm Sale |
2021-01-11 | 13G | Cytokinetics, Incorporated CYTK |
BIOTECHNOLOGY VALUE FUND L P | 2,728,035 3.900% |
-4,629,984 (-62.92%) |
Filing History |
| 2021-01-12 5:10 pm Unchanged |
2021-01-08 | 13D | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 446,194 22.300% |
0 (Unchanged) |
Filing History |
| 2021-01-11 5:06 pm Purchase |
2020-12-30 | 13G | GRITSTONE BIO INC GRTSQ |
BIOTECHNOLOGY VALUE FUND L P | 2,695,418 6.500% |
2,695,418 (New Position) |
Filing History |
| 2020-12-30 5:27 pm Purchase |
2020-12-28 | 13G | NOVUS THERAPEUTICS INC NVUS |
BIOTECHNOLOGY VALUE FUND L P | 1,518,039 10.000% |
3,520 (+0.23%) |
Filing History |
| 2020-12-28 5:13 pm Purchase |
2020-12-22 | 13G | NOVUS THERAPEUTICS INC NVUS |
BIOTECHNOLOGY VALUE FUND L P | 1,514,519 9.990% |
1,319,193 (+675.38%) |
Filing History |
| 2020-12-21 4:37 pm Purchase |
2020-12-11 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
BIOTECHNOLOGY VALUE FUND L P | 10,963,000 7.800% |
10,963,000 (New Position) |
Filing History |
| 2020-12-15 5:21 pm Unchanged |
2020-12-11 | 13D | XOMA Corporation XOMA |
BIOTECHNOLOGY VALUE FUND L P | 4,182,243 37.900% |
0 (Unchanged) |
Filing History |
| 2020-12-10 5:16 pm Sale |
2020-02-04 | 13G | Arcus Biosciences, Inc. RCUS |
BIOTECHNOLOGY VALUE FUND L P | 2,752,222 4.200% |
-826,801 (-23.10%) |
Filing History |
| 2020-11-20 5:23 pm Purchase |
2020-11-19 | 13D | Olema Pharmaceuticals, Inc. OLMA |
BIOTECHNOLOGY VALUE FUND L P | 6,661,503 16.600% |
6,661,503 (New Position) |
Filing History |
| 2020-11-16 5:29 pm Purchase |
2020-11-12 | 13G | Cytokinetics, Incorporated CYTK |
BIOTECHNOLOGY VALUE FUND L P | 7,358,019 10.400% |
3,419,739 (+86.83%) |
Filing History |